BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36617423)

  • 1. NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study.
    von Stockum S; Bauerfeind A; Becker K; Franke C; Fruzzetti F; Calaf J; Keck C; Heinemann K
    Gynecol Endocrinol; 2023 Dec; 39(1):2162036. PubMed ID: 36617423
    [No Abstract]   [Full Text] [Related]  

  • 2. Unintended pregnancy in users of nomegestrol acetate and 17β-oestradiol (NOMAC-E2) compared with levonorgestrel-containing combined oral contraceptives: final results from the PRO-E2 study.
    Reed S; Koro C; DiBello J; Becker K; Bauerfeind A; Franke C; Heinemann K
    Eur J Contracept Reprod Health Care; 2021 Dec; 26(6):447-453. PubMed ID: 34651535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study.
    von Stockum S; Becker K; Bauerfeind A; Franke C; Fruzzetti F; Calaf J; Keck C; Heinemann K
    Gynecol Endocrinol; 2023 Dec; 39(1):2166032. PubMed ID: 36690019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism.
    Reed S; Koro C; DiBello J; Becker K; Bauerfeind A; Franke C; Heinemann K
    Eur J Contracept Reprod Health Care; 2021 Dec; 26(6):439-446. PubMed ID: 34644228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the multinational, surveillance PRO-E2 study informative for all countries? The Italian data on VTE and contraceptive effectiveness.
    Fruzzetti F; Cagnacci A; Boolell M; Di Carlo C; Bruni V
    Eur J Contracept Reprod Health Care; 2024 Feb; 29(1):1-7. PubMed ID: 38085301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism.
    Ågren UM; Anttila M; Mäenpää-Liukko K; Rantala ML; Rautiainen H; Sommer WF; Mommers E
    Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):444-57. PubMed ID: 22066891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
    Gaussem P; Alhenc-Gelas M; Thomas JL; Bachelot-Loza C; Remones V; Ali FD; Aiach M; Scarabin PY
    Thromb Haemost; 2011 Mar; 105(3):560-7. PubMed ID: 21225090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β-estradiol in comparison to levonorgestrel/ethinylestradiol.
    Sørdal T; Grob P; Verhoeven C
    Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1279-85. PubMed ID: 22762147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.
    Mansour D; Verhoeven C; Sommer W; Weisberg E; Taneepanichskul S; Melis GB; Sundström-Poromaa I; Korver T
    Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):430-43. PubMed ID: 21995590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real world utilization of 91 day extended levonorgestrel-containing combined oral contraceptives in Europe: a multinational database study.
    Kaplan S; Toussi M; Evans A; Dhanda S; Roy D; Lass A
    Curr Med Res Opin; 2021 Mar; 37(3):515-522. PubMed ID: 33459071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the pharmacology, clinical outcomes, and real-world effectiveness, safety, and non-contraceptive effects of NOMAC/E2.
    Fruzzetti F; Machado RB; Lete I; Patel A; Boolell M
    Eur J Obstet Gynecol Reprod Biol X; 2024 Mar; 21():100283. PubMed ID: 38318398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea.
    Grandi G; Napolitano A; Xholli A; Tirelli A; Di Carlo C; Cagnacci A
    Gynecol Endocrinol; 2015 Oct; 31(10):774-8. PubMed ID: 26291811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17β-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women.
    Mansour D; Westhoff C; Kher U; Korver T
    Contraception; 2017 Apr; 95(4):390-397. PubMed ID: 28011288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unintended pregnancy rates differ according to combined oral contraceptive - results from the INAS-SCORE study.
    Barnett C; Dinger J; Minh TD; Heinemann K
    Eur J Contracept Reprod Health Care; 2019 Aug; 24(4):247-250. PubMed ID: 31204884
    [No Abstract]   [Full Text] [Related]  

  • 15. Nomegestrol acetate-17b-estradiol for oral contraception.
    Burke A
    Patient Prefer Adherence; 2013; 7():607-19. PubMed ID: 23836965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function.
    Ågren UM; Anttila M; Mäenpää-Liukko K; Rantala ML; Rautiainen H; Sommer WF; Mommers E
    Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):458-67. PubMed ID: 21942708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed pregnancy detection and return to fertility with extended levonorgestrel-containing oral contraceptives: A real world setting cohort study.
    Kaplan S; Bertoia ML; Lass A; Wang FT; Evans A; Dhanda S; Roy D; Seeger JD
    Pharmacoepidemiol Drug Saf; 2023 Jan; 32(1):78-83. PubMed ID: 35713281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability.
    Akintomide H; Panicker S
    Open Access J Contracept; 2015; 6():77-86. PubMed ID: 29386925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
    Lete I; Chabbert-Buffet N; Jamin C; Lello S; Lobo P; Nappi RE; Pintiaux A
    Eur J Contracept Reprod Health Care; 2015; 20(5):329-43. PubMed ID: 26007631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of therapeutic and supratherapeutic oral doses of nomegestrol acetate (NOMAC)/17β-estradiol (E2) on QTcF intervals in healthy women: results from a randomized, double-blind, placebo- and positive-controlled trial.
    de Kam PJ; van Kuijk J; Lillin O; Post T; Thomsen T
    Clin Drug Investig; 2014 Jun; 34(6):413-20. PubMed ID: 24777591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.